Key result
Wearable devices facilitate non-invasive assessment of cardiac arrhythmias, but their rapid uptake and gaps in knowledge regarding subclinical atrial fibrillation may lead to unnecessary testing.
Why the study?
Rapid uptake of wearable devices and gaps in managing conditions such as subclinical atrial fibrillation risk unnecessary downstream testing, requiring clinician understanding.
Wearable devices offer potential for non-invasive arrhythmia detection but may lead to unnecessary downstream testing due to knowledge gaps in managing subclinical atrial fibrillation.
Wearables may aid arrhythmia detection in consumers; gaps in optimal integration leave clinical adoption open for prospective study.
There has been increased consumer uptake of smart devices and wearable technology. They facilitate non-invasive, ambulatory assessment of numerous cardiac indices, including the heart rate and rhythm. Several studies have reported on the utility and deficiencies of these devices in identifying and monitoring cardiac arrhythmias. The rapid uptake of these consumer devices has the potential to generate vast amounts of biometric data. This coupled with gaps in knowledge pertaining to the optimal management of conditions such as sub clinical atrial fibrillation, may result in unnecessary and expensive downstream testing. An improved understanding of this nascent field by the clinician is vital.
No takes yet. Share an insight, caveat, or question.
Sajeev et al. (2019) conducted a review in Cardiac arrhythmias. Wearable devices and smart technology was evaluated. Wearable devices facilitate non-invasive assessment of cardiac arrhythmias, but their rapid uptake and gaps in knowledge regarding subclinical atrial fibrillation may lead to unnecessary testing.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: